This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Basal Insulins - Pharmacodynamics

This study has been completed.
The Danish Diabetes Association
The Institute of Experimental Clinical Research, University of Aarhus
Novo Nordisk A/S
Information provided by:
University of Aarhus Identifier:
First received: November 30, 2007
Last updated: NA
Last verified: November 2007
History: No changes posted
To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.

Condition Intervention Phase
Diabetes Drug: Insulin detemir Drug: Insulin glargine Drug: Insulatard Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: No Evidence for Essential Differences Between the Effects of Insulin Glargine, Insulin Detemir and NPH Insulin on Glucose Metabolism After a Single Injection as Assessed by 24-h Euglycemic Clamp Studies in Healthy Humans

Resource links provided by NLM:

Further study details as provided by University of Aarhus:

Primary Outcome Measures:
  • Area under GIR-curve, maximal glucose infusion rate, time to maximal glucose infusion rate. [ Time Frame: 24 hours ]

Enrollment: 10
Study Start Date: January 2005
Study Completion Date: May 2005
Arms Assigned Interventions
Active Comparator: 1
Insulin detemir
Drug: Insulin detemir
0.4 U/kg bw insulin detemir injected s.c. in the thigh.
Other Name: Levemir
Active Comparator: 2
Insulin glargine
Drug: Insulin glargine
0.4 U/kg bw insulin glargine injected s.c. in the thigh
Other Name: Lantus
Active Comparator: 3
NPH insulin
Drug: Insulatard
0.4 U/kg bw NPH insulin injected s.c. in the thigh

Detailed Description:
In this randomized, double-blind, euglycemic glucose clamp study, 10 healthy male volunteers received a subcutaneous injection of 0.4 U/kg insulin detemir, insulin glargine or NPH insulin on three separate study days in a cross-over design. After insulin administration, plasma glucose was maintained at 0.3 mmol/l below fasting level for 24 hours by manually adjusted glucose infusion. C-peptide, insulin, NEFA and counter regulatory hormones were measured throughout the clamp period. Endogenous glucose release (EGR) was assessed by the isotope dilution technique (3-3H-glucose).

Ages Eligible for Study:   20 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Male
  • BMI 20 - 50 kg/m2
  • Blood pressure < 140/90 mmHg
  • signed informed consent
  • Caucasien

Exclusion Criteria:

  • Diabetes or other disease
  • Alcohol or drug abuse
  • Smoking
  • Use of prescription drugs
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00566124

Medical department M (Endocrinology and Diabetes), Aarhus University Hospital
Aarhus, DK, Denmark, 8000
Sponsors and Collaborators
University of Aarhus
The Danish Diabetes Association
The Institute of Experimental Clinical Research, University of Aarhus
Novo Nordisk A/S
Principal Investigator: Ole E. Schmitz, DMSc University of Aarhus
  More Information

Responsible Party: Ole E. Schmitz, DMSc., University of Aarhus Identifier: NCT00566124     History of Changes
Other Study ID Numbers: Opus 1
Study First Received: November 30, 2007
Last Updated: November 30, 2007

Keywords provided by University of Aarhus:
Levemir, Lantus, Insulatard, Pharmacodynamics, Healthy humans

Additional relevant MeSH terms:
Insulin, Globin Zinc
Isophane insulin, beef
Insulin Glargine
Insulin Detemir
Insulin, Isophane
Isophane Insulin, Human
Hypoglycemic Agents
Physiological Effects of Drugs processed this record on August 16, 2017